Search results
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 5 days agoHowever, the company's research and development expenses decreased to $15.4 million from $18.3 million in Q1 2023, reflecting cost efficiencies...continues to defend its intellectual ...
Morning Brew: Tesla's Innovative Patent Sparks Investor Interest
Guru Focus· 1 day agoStock market futures are showing optimism this morning, with S&P 500 futures up by 18 points (0.3%),...
Interest rates and the AI-fueled rally remain top of mind for stock investors in the week ahead
CNBC· 4 days agoAs investors say farewell to a week marked by a Federal Reserve meeting, surprise labor market data...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK (NYSE:GSK)
Benzinga· 6 days agoVaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand...